NACC1 and ovarian cancer: To determine the possible mechanism by which NAC1 promotes drug resistance, we used the quantitative proteomics to compare the proteomes of N130-induced and-noninduced SKOV3 ovarian cancer cells using tandem mass spectrometry (MS/MS) and spectral count [11].